Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franz, M. G.
Right arrow Articles by Gower, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franz, M. G.
Right arrow Articles by Gower, W. R., Jr

Annals of Surgical Oncology, Vol 3, Issue 6 564-569, Copyright © 1996 by Society of Surgical Oncology

ARTICLES

Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms

M. G. Franz, J. G. Norman, P. J. Fabri and W. R. Gower Jr
Department of Surgery, University of South Florida College of Medicine, Tampa, USA.

BACKGROUND: The signal transduction pathways important in regulating the growth and differentiation of malignant cells are poorly understood. Recent evidence has implicated activation of the protein kinase C (PKC) family of signaling proteins in pancreatic carcinoma during cytokine-induced cytostasis and differentiation. METHODS: A human pancreatic adenocarcinoma (HPAC) cell line was exposed to tumor necrosis factor-alpha (TNF-alpha; 40 ng/ml) for 6 days. Cytostasis and viability were confirmed by daily MTT [(3(4,5)-dimethyl-thiazol-2-yl) 2,5-diphenyl-tetrazolium bromide] and trypan exclusion assay. Protein fractions were isolated daily and subjected to immunoblot analysis for the normal (terminally differentiated) pancreatic ductal cell marker carbonic anhydrase II (CA II) as well as specific PKC isoforms (alpha, beta, gamma, eta, and zeta). RESULTS: Growth arrest occurred in HPAC cells after exposure to TNF-alpha for 48 h, with viability maintained above 90% throughout the 6-day time course. CA II immunoreactivity was not detected in untreated controls but appeared after 2 days of TNF-alpha exposure, peaking on day 6. Concurrently, TNF-alpha induced the selective downregulation of PKC-alpha, whereas PKC-gamma levels increased. PKC-beta and PKC-eta immunoreactivity did not change. The atypical PKC-zeta isoform developed a doublet banding pattern in response to TNF-alpha, although overall PKC-zeta levels did not change. CONCLUSIONS: TNF-alpha-induced growth arrest and differentiation in HPAC cells is associated with the selective downregulation of PKC-alpha and upregulation of PKC-gamma.


This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. Guha, J. A. Lunn, C. Santiskulvong, and E. Rozengurt
Neurotensin Stimulates Protein Kinase C-dependent Mitogenic Signaling in Human Pancreatic Carcinoma Cell Line PANC-1
Cancer Res., May 15, 2003; 63(10): 2379 - 2387.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Rosenzweig, L. Braiman, A. Bak, A. Alt, T. Kuroki, and S. R. Sampson
Differential Effects of Tumor Necrosis Factor-{alpha} on Protein Kinase C Isoforms {alpha} and {delta} Mediate Inhibition of Insulin Receptor Signaling
Diabetes, June 1, 2002; 51(6): 1921 - 1930.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Guha, O. Rey, and E. Rozengurt
Neurotensin Induces Protein Kinase C-dependent Protein Kinase D Activation and DNA Synthesis in Human Pancreatic Carcinoma Cell Line PANC-1
Cancer Res., March 1, 2002; 62(6): 1632 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
K. Detjen, F. Brembeck, M Welzel, A Kaiser, H Haller, B Wiedenmann, and S Rosewicz
Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest
J. Cell Sci., January 9, 2000; 113(17): 3025 - 3035.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society of Surgical Oncology.